Monoclonal Gammopathy of Renal Significance
Conditions
Keywords
Paraproteinemias[Mesh], Kidney Diseases[Mesh]
Brief summary
This is the first prospective study which evaluate patients with small B-cell clones to diagnose monoclonal gammopathy of renal significance (MGRS) and characterize it clinically, anatomopathologically and pathophysiologically taking int account a geriatric approach.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Paraproteinemias
Exclusion criteria
* Multiple Myeloma * Waldenstrom Macroglobulinemia * Chronic Lymphocytic Leukemia * Malignant Lymphoma * Monoclonal gammopathy of unknown significance (MGUS) secondary to Infections * MGUS secondary to Autoimmune Diseases * Uncompleted hematological evaluation * Renal tumor except for cysts Bosniak type I/II * Other malignant neoplasia * Unresolved obstructive uropathy * Patients with only one kidney except for renal transplant * Co-morbidities which would limit the ability to receive aggressive therapeutic intervention * Fragile old people * Pregnancy * Prison * Impatient in psychiatric institutions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Renal histopathology compatible with MGRS | through study completion, an average of 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Renal physiopathological changes | through study completion, an average of 1 year |
Countries
Argentina